RxDoctor Payments Data

Christopher Pelton

Family · Overland Park, KSNPI 1184016529

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 332 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 43 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,591in general payments, 2019–2025

Across 332 payments — averaging $16.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$846
  • Novo Nordisk$790
  • Lilly USA, LLC$323
  • Pfizer$284
  • Amgen$274
  • plus $2K from 37 others

What the payments were for

  • Food & beverage$5,565100%
  • Education$260%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,591 in reported general payments places this provider in the 95th percentile of 1,579 family providers in Kansas.

See all family providers in Kansas

Medicare billing

Part B allowed, 2024
$27,495
Medicare patients
272
Services billed
575

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide16$15,443
EliquisApixaban11$9,749
Levothyroxine Sodium82$933
Albuterol Sulfate HfaAlbuterol Sulfate26$725
Atorvastatin Calcium82$700
Duloxetine Hcl25$688
Gabapentin47$681
Metformin Hcl ErMetformin Hcl35$653
Rosuvastatin Calcium63$548
Esomeprazole Magnesium15$534
Losartan Potassium62$517
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine16$443
Pantoprazole Sodium34$440
Metoprolol Succinate44$427
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide22$413

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$790$15,44316 claims
PfizerEliquis$284$9,74911 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$17$93382 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,579 family providers in Kansas.

Other family in Overland Park

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →